Reduced hepatic injury in toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure

Cellular Physiology and Biochemistry

Volumn 29, Issue 1-2, 2012, Pages 41-50

  Ben Ari, Ziv ^a,b   Avlas, Orna ^b,c   Pappo, Orit ^a   Zilbermints, Veacheslav ^a   Cheporko, Yelena ^b   Bachmetov, Larissa ^b   Zemel, Romy ^b   Shainberg, Asher ^c   Sharon, Eran ^a   Grief, Franklin ^a   Hochhauser, Edith ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

Author keywords

cJun; GalN LPS; I B; TNF

Indexed keywords

CASPASE 3; GALACTOSAMINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LIVER ENZYME; MESSENGER RNA; PROTEIN C JUN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FULMINANT HEPATIC FAILURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MUS;

EID: 84859833378     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000337585     Document Type: Article

References (42)

1. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH: Acute liver failure: Summary of a workshop. Hepatology 2008;47:1401-1415. (Pubitemid 351547926)
2. Rolando N, Philpott-Howard J, Williams R: Bacterial and fungal infection in acute liver failure. Semin Liver Dis 1996;16:389-402. (Pubitemid 27074781)
3. Chosay JG, Essani NA, Dunn CJ, Jaeschke H: Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol 1997;272:G1195-G1200.
4. Xiong Q, Hase K, Tezuka Y, Namba T, Kadota S: Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharideinduced liver injury. Life Sci 1999;65:421-430. (Pubitemid 29325285)
5. Galanos C, Freudenberg MA, Reutter W: Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979;76:5939-5943. (Pubitemid 10216692)
6. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995;146:1220-1234.
7. Bohlinger I, Leist M, Gantner F, Angermuller S, Tiegs G, Wendel A: Dann fragmentation in mouse organs during endotoxin shock. Am J Pathol 1996;149:1381-1393. (Pubitemid 26337255)
8. Martich GD, Danner RL, Ceska M, Suffredini AF: Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of anti inflammatory agents. J Exp Med 1991;173:1021-1024.
9. Leist M, Gantner F, Jilg S, Wendel A: Activation of the 55 kDa TNF receptor is necessary and sufficient for TNFinduced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995;154:1307-1316.
10. Kawaguchi K, Kikuchi S, Hasegawa H, Maruyama H, Morita H, Kumazawa Y: Suppression of lipopolysaccharideinduced tumor necrosis factor-release and liver injury in mice by naringin. Eur J Pharmacol 1999;368:245-250. (Pubitemid 29117146)
11. Seki E, Brenner DA: Toll-like receptors and adaptor molecules in liver. Hepatology 2008;48:322-335. (Pubitemid 351975556)
12. Werling D, Jungi TW: Toll-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol 2003;91:1-12. (Pubitemid 36042793)
13. Qureshi ST, Gros P, Malo D: Host resistance to infection: genetic control of lipopolysaccharide responsiveness by toll-like receptor genes. Trends Genet 1999;15:291-294.
14. Medvedev AE, Kopydlowski KM, Vogel SN: Inhibition of lipopolysaccharideinduced signal transduction in endotoxintolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 2000;164:5564-5574. (Pubitemid 30389795)
15. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J Immunol 1999;162:3749-3752. (Pubitemid 29314747)
16. Roger T, Froidevaux C, Le Roy D, Reymond MK, Chanson AL, Mauri D, Burns K, Riederer BM, Akira S, Calandra T: Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci U S A 2009;17;106:2348-2352.
17. Ojaniemi M, Liljeroos M, Harju K, Sormunen R, Vuolteenaho R, Hallman M: TLR-2 is upregulated and mobilized to the hepatocyte plasma membrane in the space of Disse and to the Kupffer cells TLR-4 dependently during acute endotoxemia in mice. Immunol Lett 2006;102:158-168. (Pubitemid 43053085)
18. Fallach R, Shainberg A, Avlas O, Fainblut M, Chepurko Y, Porat E, Porat E, Hochhauser E: Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia. J Mol Cell Cardiol 2010;48:1236-1244.
19. Bernal W, Auzinger G, Dhawan A, Wendon J: Acute liver failure. Lancet 2010;17:376:190-201.
20. Alcorn JM, Fierer J, Chojkier M: The acute-phase response protects mice from d-galactosamine sensitization to endotoxin and tumor necrosis factoralpha. Hepatology 1992;15:122-129.
21. Diaz-Buxo JA, Blumenthal S, Hayes D, Gores P, Gordon B: Galactosamineinduced fulminant hepatic necrosis in unanesthetized canines. Hepatology 1997;25:950-957. (Pubitemid 27157140)
22. Mignon A, Rouquet N, Fabre M, Martin S, Pagès JC, Dhainaut JF, Kahn A, Briand P, Joulin V: LPS challenge in Dgalactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med 1999;159:1308-1315. (Pubitemid 29202572)
23. Decker K, Keppler D: Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 1974;71:77-106.
24. Silverstein R: D-galactosamine lethality model: scope and limitations. J Endotoxin Res 2004;10:147-162. (Pubitemid 38877735)
25. Wheeler MD, Yamashina S, Froh M, Rusyn I, Thurman RG: Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-kappaB activation and cytokine production. J Leukoc Biol 2001;69:622-630. (Pubitemid 32297611)
26. Hoffmann F, Sass G, Zillies J, Zahler S, Tiegs G, Hartkorn A, Fuchs S, Wagner J, Winter G, Coester C, Gerbes AL, Vollmar AM: A novel technique for selective NFkappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion. Gut 2009;58:1670-1678.
27. Lu JW, Wang H, Yan-Li J, Zhang C, Ning H, Li XY, Zhang H, Duan ZH, Zhao L, Wei W, Xu DX: Differential effects of pyrrolidine dithiocarbamate on TNFalpha-mediated liver injury in two different models of fulminant hepatitis. J Hepatol 2008;48:442-452.
28. Pfeffer K, Matsuyama T, Kündig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Krönke M, Mak TW: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993;73:457-467. (Pubitemid 23143346)
29. Marino M, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ: Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997;94:8093-8098. (Pubitemid 27343782)
30. Freudenberg M, Keppler D, Galanos C: Requirement for lipopolysaccharideresponsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun 1986;51:891-895. (Pubitemid 16162992)
31. Freudenberg MA, Galanos C: Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in Dgalactosamine-treated mice. Infect Immun 1991;59:2110-2115.
32. Matsumura T, Ito A, Takii T, Hayashi H, Onozaki K: Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 2000;20:915-921.
33. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088. (Pubitemid 29001265)
34. Kitazawa T, Tsujimoto T, Kawaratani H, Fujimoto M, Fukui H: Expression of Tolllike receptor 4 in various organs in rats with D-galactosamine-induced acute hepatic failure. J Gastroenterol Hepatol 2008;23:e494-e498.
35. Wang H, Li Y: Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and dgalactosamine in mice. Eur J Pharmacol 2006;534:194-201. (Pubitemid 43384201)
36. Kitazawa T, Tsujimoto T, Kawaratani H, Fukui H: Salvage effect of E5564, Tolllike receptor 4 antagonist on dgalactosamine and lipopolysaccharideinduced acute liver failure in rats. J Gastroenterol Hepatol 2010;25:1009-1012.
37. Takamura M, Matsuda Y, Yamagiwa S, Tamura Y, Honda Y, Suzuki K, Ichida T, Aoyagi Y: An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins. Life Sci 2007;13:80:1335-1344.
38. Kim SJ, Kim JK, Lee DU, Kwak JH, Lee SM: Genipin protects lipopolysaccharide-induced apoptotic liver damage in D- galactosaminesensitizedmice. Eur J Pharmacol 2010;635:188-193.
39. Hong JY, Lebofsky M, Farhood A, Jaeschke H: Oxidant stress-induced liver injury in vivo: role of apoptosis, oncotic necrosis, and c-Jun NH2-terminal kinase activation. Am J Physiol 2009;296:G572-G581.
40. Ip YT, Davis RJ: Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 1998;10:205-219. (Pubitemid 28174763)
41. Becker C, Barbulescu K, WirtzS, Meyer zum Buschenfelde KH, Pettersson S, Neurath MF: Constitutive and inducible in vivo protein-DNA interactions at the tumor necrosis factor-alpha promoter in primary human T lymphocytes. Gene Expr 1999;8:115-127. (Pubitemid 29528721)
42. Wang Y, Singh R, Lefkowitch JH, Rigoli RM, Czaja MJ: Tumor necrosis factorinduced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J Biol Chem 2006;281:15258-15267. (Pubitemid 43855115)